If they can get the pps to $1+ by then, they will deserve those performance shares, despite the major stuff up in the 1st US clinical trial (it did allow me to buy a lot of shares cheap.....), if they can't achieve that pps, they don't deserve it.
- Forums
- ASX - By Stock
- RAP
- The dawn of Revenue for RAP
The dawn of Revenue for RAP, page-21
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online